Definitive Contract 75D30123C18193

Award Date 9/29/23

Potential Completion Date 9/28/24

Potential Value $525K

Federal Agency

CDC Pittsburgh

Awardee

Geisinger Clinic JQH2GEMCAVN5

Ultimate Awardee

Not listed

NAICS Category

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

PSC Category

AN11 - Health R&D Services; Health Care Services; Basic Research

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Cost No Fee

Place of Performance

Danville, PA 17822, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Legislative Mandate

Employment Eligibility Verification

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

The U.S. Centers for Disease Control and Prevention (CDC) has awarded a $525,235.25 definitive contract to Geisinger Clinic, doing business as Geisinger Health Group, for a demonstration project titled "Combining Trust, Technology & Theory in the Community to Prevent Diabetes: A Demonstration Project with Black Barbers & Stylists". The contract, which is not set aside, has a completion date of September 28, 2024. Geisinger Clinic is a subsidiary of Geisinger Health System Foundation, a large integrated healthcare provider in Pennsylvania. The contract aims to leverage Geisinger's expertise in areas like epidemiology, implementation science, and community outreach to support a diabetes prevention initiative targeting Black communities through partnerships with local barbers and stylists.

Generated 6/25/24, 1:49 PM

Mod #	ReasonForModification	Federal Obligation	Date
P00002	Other Administrative Action	$0	6/24/24
P00001	Other Administrative Action	$0	1/31/24
Not listed	Not listed	$525.2k	9/22/23